PDCD1LG2 and melanoma: PD-L2 expression by tumor cells was further associated with a better prognosis in oropharyngeal squamous cell carcinoma and melanoma and with a worse prognosis in colorectal cancer, malignant salivary gland tumors, and chromophobe renal cell carcinoma.